BioMimetic Triumphs Over Investors' Fraud Class Action
A Tennessee federal judge on Thursday tossed a shareholder class action against BioMimetic Therapeutics Inc. and its two top executives, ruling that the plaintiffs had failed to prove the orthopedics company...To view the full article, register now.
Already a subscriber? Click here to view full article